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http://dx.doi.org/10.1016/j.jmii.2015
1684-1182/Copyright ª 2015, TaiwanAbstract Purpose: To compare the performance of a commercial interferon-gamma release
assay, QuantiFERON TB Gold-in-Tube (QFG-IT) with the tuberculin skin test (TST) in Taiwanese
children for the diagnosis of active tuberculosis (TB).
Methods: A retrospective chart analysis of pediatric patients (<18 years of age) who under-
went QFG-IT tests and TST for the confirmation of active TB between January 2008 and June
2014.
Results: The sensitivity of QFG-IT was 100% [95% confidence interval (CI): 63.1e100],
versus sensitivity of 62.5% for TST (95% CI 24.5e91.5). The positive predictive value of
QFG-IT was 100 (95% CI: 89.7e100), while the negative predictive value for TST was
86.9% (95% CI: 67e96.3). Among three patients with Bacillus CalmetteeGue´rin (BCG)
osteitis, two patients with TST were positive, but all tested samples for QFG-IT were
negative.
Conclusion: QFG-IT assay was more sensitive for the diagnosis of TB disease than TST in
an intermediate burden population with universal neonatal BCG vaccination. The
increased recognition of BCG induced osteitis in recent years has alerted physicians that
BCG induced lesions should be suspected when TST is positive but QFG-IT is negative.ediatric Pulmonology, Department of Pediatrics, Chang Gung Children’s Hospital, 5 Fu Hsin Street,
com (K.-S. Wong).
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active TB and should be performed when a diagnosis of TB remains in doubt.
Copyright ª 2015, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
In Taiwan, the incidence of tuberculosis (TB) in the year
2000 was 70/100,000 person/year in adults, and less than 5/
100,000 in children younger than 5 years of age.1 Since 1960,
the national Bacillus CalmetteeGue´rin (BCG) vaccination
program had been instituted in Taiwan with a coverage rate
of 97% in infancy.2 Tuberculin skin test (TST) has been useful
for the diagnosis of TB infections and diseases, but is not
able to discriminate between the two; furthermore, the
distinction between TB infections and BCG vaccination is not
possible using TST. Interferon-gamma (IFN-g) release assays
(IGRAs) have the advantage of a higher specificity than TST,
at the same time IGRAs do not cross-react with BCG vacci-
nation and most nontuberculous mycobacterial (NTM)
strains.3 IGRAs do not have a booster effect in patients who
require repeated examinations. The inclusion of mitogen
response in IGRAs has the added capability of exclusion of
immunological anergy.
Commercial IGRAs can be used to distinguish the pro-
duction of IFN-g in response to Mycobacterium tuberculosis
infection from the BCG vaccine.4,5 IGRAs have been rec-
ommended for use in children with a positive TST who
received BCG vaccinations, to avoid unnecessary chemo-
prophylaxis.3 However, comparative studies using com-
mercial QuantiFERON TB Gold-in-Tube (QFG-IT) assay and
the TST in an endemic region where national neonatal BCG
program were instituted are nonexistent. The objective of
the present study was to compare the performance of a
commercial IGRA (QFG-IT), with the TST in a cohort of
pediatric patients in a high neonatal BCG vaccination up-
take population. The recruited patients consisted of chil-
dren with clinically suspected active TB in an intermediate-
burden region. We calculated the sensitivity and specificity
of QFG-IT for the diagnoses of TB diseases using microbio-
logical culture and histo-pathological findings of granuloma
formations as the golden standard. Demographic data,
clinical manifestations, and laboratory data were analyzed.
Methods
Patient population
A computerized search of our database of pediatric pa-
tients (<18 years of age) who underwent QFG-IT tests were
recruited for the confirmation of active TB between
January 2008 and June 2014.
Inclusion criteria
All children aged between 2 months and 18 years who were
investigated for active TB with the performance of QFG-IT
tests were included.ong K-S, et al., Diagnostic utilit
al of Microbiology, Immunology anExclusion criteria
The patients who were referred solely for contact tracing
after exposure to active TB were excluded when sputum,
gastric lavage fluid for acid-fast bacteria (AFB) staining,
and culture for TB were not performed.
Definition of study groups
Active TB: Cases of active TB were defined according to the
following three categories: (1) definite TB: all children had
culture-confirmed TB; (2) probable TB: children in this
group had symptoms and signs of active TB but had no
bacterial confirmation; abnormal radiography consistent
with TB and/or response to TB therapy; and (3) possible TB:
signs and symptoms consistent with active TB and existing
risk factors for active TB, such as history of TB contact.
Tuberculin skin testing
Two units (0.2 mL) of purified protein derivative RT23
(Staten Serum Institute, Copenhagen, Denmark) were
applied to the volar surface of the left lower forearm ac-
cording to the intradermal Mantoux method. The transverse
diameter of skin induration recorded in millimeters 48e72
hours later were retrieved from the medical chart. Indu-
ration >10 mm was considered positive.
Laboratory assays
Peripheral blood samples were obtained for IGRAs accord-
ing to the manufacturer’s recommendations. All blood
samples were processed within 4 hours of blood collection.
The commercially available QFG-IT assays (Cellestis, Car-
negie, Australia) were used in all examinations.
The cut-off value for a positive IFN-g production in
response to the QFG-IT were interpreted as positive if the
IFN-g level in response to Early Secreted Antigenic Target 6
kDa (ESAT-6), Culture Filtrate Protein 10 kDa (CFP10), or
tuberculosis antigen (TB 7.7) was 0.35 IU/mL and 25% of
the background value. The values were interpreted as
negative if the IFN-g level was <0.35 IU/mL or <25% of
the background value, with the IFN-g level in response to
mitogen (the positive control) reaching at least 0.5 IU/mL.
The result was interpreted as indeterminate if the IFN-g
level was <0.35 IU/mL or <25% of background value with
the IFN-g level in response to mitogen <0.5 IU/mL, or if the
negative control was positive, irrespective of the IFN-g
response to ESAT-6, CFP-10, or TB 7.7 was set at 0.35 IU of
IFN-g. Absolute levels of antigen specific IFN-g were
calculated by subtracting the value of the negative control
from the antigen-specific value.y of QuantiFERONeTB Gold In-Tube test in pediatric tuberculosis
d Infection (2015), http://dx.doi.org/10.1016/j.jmii.2015.07.012
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The institutional review board of Chang Gung Memorial
Hospital approved the retrospective review of patients’
chest radiographs and medical records for this study (CGMH
103-5143B). Informed consent was waived because of the
retrospective nature of this study.
Statistical analysis
Non-normally distributed variable were present as median
and range. The performance of TST and QFG-IT were
assessed by calculating their sensitivity, specificity, positive
predictive value (PPV), and negative predictive value
(NPV). Statistical analyses were performed using Stat 11
(Stat, Inc, College Station, TX, USA).Results
Between January 2008 and June 2014, 70 children who had
undergone the QFG-IT test in the Chang Gung Children’s
Hospital for active TB disease surveillance were enrolled
into the study. Twenty-three cases were excluded from
analysis because they were studied solely as contact
investigation of TB without further bacteriologic or patho-
logic confirmation (Figure 1).
A total of 47 cases of suspected TB infections underwent
QFG-IT tests. Eight patients had proven active TB disease,
seven of them were confirmed using bacterial isolation, and
one had “probable” TB by the pathologic finding of granu-
loma formations in the knee (Table 1). The median age of
this cohort of patients was 10.2 years (range, 2.5 months to
18 years). There are 27 male and 20 female patients in the70 patients with QFG-IT
Exclusion 23 patients
No sputum analysis or tissue biopsy
QFG-IT positive: 8 
patients
QFG-IT negative: 36 patients
QFG-IT indeterminate: 3 patients
47 pediatric patients with QFG-IT and bacteriological studies 
completed or histological proof
M. tuberculosis disease = 8
M. bovis = 3
NTM = 1
No TB infection n = 35
Figure 1. Flow chart of the study population. Of 70 patients
with suspected pulmonary tuberculosis recruited, 47 were
eligible for inclusion in the final analysis. QFG-
IT Z QuantiFERON-TB Gold in-Tube; NTM Z nontuberculous
mycobacterium; TB Z tuberculosis.
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bid diseases included: antineutrophil cytoplasmic antibody-
associated vasculitis and chronic kidney disease postrenal
transplantation (n Z 1); acute myeloblastic leukemia
(n Z 1); acute lymphoblastic leukemia with peripheral
blood progenitor cell transplantation (n Z 1), Hodgkin
lymphoma (n Z 1), common variable immunodeficiency
with bronchiectasis (n Z 1); transient hypo-
gammaglobulinema of infancy (n Z 1), diabetes mellitus
(n Z 1).
The presenting symptoms for the evaluation of TB dis-
ease were: pneumonia (n Z 21), pleural effusion (n Z 8),
lymphadenopathy/neck mass/axillary mass (n Z 7), fever
of unknown origin (n Z 6), hemoptysis/bloody sputum
(nZ 6), bone or joint pain (nZ 4), chronic cough >3 weeks
(n Z 3), respiratory distress or sepsis (nZ 2), unexplained
body weight loss (n Z 2), single cases of abdominal
distention, chest wall bulging, and seizure respectively.
Three patients had indeterminate QFG-IT results and
were later confirmed not to have mycobacterial disease.
The clinical profiles of the patients with definite TB disease
and “probable” TB disease were presented in the Table 2.
One patient suffered from acute lymphoblastic leukemia
had allogeneic peripheral blood progenitor cell trans-
plantation was diagnosed as having pulmonary non-
tuberculous mycobacterium (NTM) infection. Three
patients had BCG related disease in the study. Case 10
presented with left knee pain for half a year before visiting
our hospital. Case 11 was brought to our hospital due to
weakness of lower limbs, which turned out to be BCG
thoracic spondylitis (Figures 2 and 3). Case 12 was evalu-
ated due to progressive parasternal protrusion for 1 month
prior to referral (Figure 4).
The diagnostic results of TB infections in these 47 pa-
tients using TST, QFG-IT assays, and polymerase chain re-
action (PCR) were tabulated in Table 3. TST has a
sensitivity of 62.5%, specificity 57.1%, PPV of 62.5%, and
NPV 87.5%. Regarding the QFG-IT test, the sensitivity,
specificity, PPV, NPV were 100%, 97.6%, 88.9%, and 100%
respectively (Table 2).Discussion
In this retrospective study, 47 children were investigated
for active TB by complete bacteriologic studies, as well as
tests including TST, QFG-IT, and PCR. In this study only
seven patients were bacteriologically-proven. The number
was small because it reflected the true clinical conditions.
IGRAs were not performed at extra expense for those pa-
tients with obvious clinical features of TB, consistent
radiographic findings and positive AFB microscopy. Most
patients in this study who underwent exhaustive examina-
tions represented cases with complicating clinical condi-
tions or equivocal laboratory results. The diagnosis of
active TB has been difficult due to its paucibacillary na-
ture.4 The stringent bacteriology confirmation of TB in this
study suggests that the diagnosis of TB disease in some
children may be missed.
TST has been used to identify persons with TB infections
but is notorious for false-positive and false-negative
results.6e9 The two most common causes of false positivey of QuantiFERONeTB Gold In-Tube test in pediatric tuberculosis
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Table 1 Clinical features and laboratory results of 12 patients with a confirmed diagnosis of active tuberculosis.
Case Age Sex Presentation Diagnosis TST QFG-IT AFB stain TB culture TB PCR
Sputum/
GA
other Sputum/
GA
Other Sputum/
GA
Other
1 15y F Fever for 6 d Pul TB þ TB
pleurisy
neg þ þ ND þ ND ND PE neg-
2 17y 1mo M Cough for 1 mo TB pleurisy þ þ Neg PE neg þ PE neg neg PE neg
3 15y 6mo M Cough for 1mo Pul TB þ þ þ ND þ ND ND ND
4 8y 11mo F Fever for 8 d TB pericarditis,
clavicle TB
neg þ Neg CE neg
Bone neg
neg CE neg
Bone
neg
ND CE neg
Bone þ
5 16y 8mo M Abdominal
distention
TB peritonitis neg þ Neg Ascites þ neg þ ND Ascites þ
6 8mo F Fever and
seizure
TB meningitis neg þ Neg CSF neg þ CSF þ þ CSF neg
7 18y M Chronic cough Pul TB þ þ þ ND þ ND þ ND
8 16y F Abnormal
screening CXR
Pul TB þ þ Neg ND þ ND ND ND
9 15y 2mo F SOB, bloody
sputum
Pul NTM
APBPCT
ND neg þ ND MAC ND complex
neg
ND
10 3y M Left knee pain
for
half year
BCG arthritis þ neg ND Tissue
neg
ND Tissue
neg
ND Tissue
BCG þ
11 1y 5mo F Bone pain and
walking
difficulty
BCG spondylitis,
T7-8
þ neg Neg Tissue þ neg Tissue
BCG þ
ND Tissue
BCG þ
12 1y M Parasternal
elevation
BCG sternal
abscess
ND neg ND ND neg Tissue
BCG þ
ND Tissue
BCG þ
AFB Z acid fast bacilli; APBPCT Z allogeneic peripheral blood progenitor cell transplantation; BCGZ Bacillus CalmetteeGue´rin;
CE Z cardiac effusion; CSF Z cerebrospinal fluid; CVID Z common variable immunodeficiency; GLF Z gastric lavage fluid; ND Z not
done; neg Z negative; NTM Z nontuberculous mycobacterium; PCR Z polymerase chain reaction; PE Z pleural effusion;
Pul Z pulmonary; QFG-IT Z QuantiFERON-TB Gold in-Tube; SOB Z shortness of breath; TST Z tuberculin test.
Table 2 Significance of laboratory results regarding mycobacterium infections.
TST QFG-IT PCR
Pos Nega ND Pos Nega ND Pos Nega ND
Mycobacterium tuberculosis disease (n Z 7 þ 1b) 5 3 0 8 0 0 1 3 4
No M. tb infection (n Z 35) 1 20 14 1 31 þ 3* 0 0 15 20
M. bovis infection (n Z 3) 2 0 1 0 3 0 3 0 0
NTM (n Z 1) 0 0 1 0 1 0 0 1 0
a Indeterminates were considered negative in this study.
b Probable tuberculosis by biopsy with caseous necrosis but acid fast bacteria negative.
ND Z not done; Neg Z negative; NTM Z nontuberculous mycobacterium; PCR Z polymerase chain reaction; Pos Z positive; QFG-
IT Z QuantiFERON-TB Gold in-Tube; TST Z tuberculin skin test.
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The specificity of IGRAs has been reported to be higher than
TST, because the antigens used are not found in BCG or
most NTM infections, except for M. kansaii, M. szulgai, and
M. marinum.3,10 The sensitivity and specificity of TST of our
study for BCG vaccinated children were 62.5% and 95.2%,
respectively, with a comparable sensitivity of 50% to 70%
and a higher specificity of 49% to 65% in literature.6,9 In this
study, an even higher sensitivity of 100% and specificity of
97.6% for the QFG-IT tests were found, as compared with
previous reference of 60e80% and 89e100% of BCG-
vaccinated children.11e14 The high sensitivity andPlease cite this article in press as: Wong K-S, et al., Diagnostic utilit
disease in Taiwanese children, Journal of Microbiology, Immunology anspecificity of the QFG-IT tests can be attributed to highly
selectivity of the patients of this study, because we only
recruited highly probable TB patients so as to not include
patients with latent TB infections.
IGRAs are the preferred test for TB infections in immu-
nocompetent children 5 years of age with previous BCG
vaccination. For children <5 years, 48 out of 50 children
had good correlation between TST and QFT-IT had been
reported.14 In our study, only five (10.6%) patients were
immunocompromised. No meaningful result regarding QFT-
IT tests for young age and immunodeficiency conditions had
been possible.y of QuantiFERONeTB Gold In-Tube test in pediatric tuberculosis
d Infection (2015), http://dx.doi.org/10.1016/j.jmii.2015.07.012
Figure 2. Bilateral paraspinal bulging between thoracic 6
and vertebrae 9 (arrows).
Figure 3. Chest lateral view reveals spondylitis of T7-8 with
angular kyphosis and gibbus deformity (arrow).
Figure 4. Chest computed tomography scan at low lung field
reveals fusiform abscess at sternum with central necrosis
(arrow).
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fections from disease.3e6,15 In our study we excluded pa-
tients with latent TB infections, therefore the number of
patients with false positive results decreases, resulting an
increase of PPV.5,16,17 The significance of negative IGRA
tests remains controversial, however, the diagnosis of TB is
very unlikely with a negative IGRA result.12
According to Table 1, nine specimens were sent for TB-
PCR study, four of them were negative: pleural effusion
(n Z 2), pericardial effusion (n Z 1), and cerebrospinal
fluid (n Z 1). Diagnosis of pleural TB is challenging due to
its nonspecific clinical presentation and paucibacillary na-
ture. Direct testing for AFB and culture of pleural fluid, lack
sensitivity (<5% and 40%, respectively), but TB-PCR may
increase sensitivity to 42%.18 Most of the time, definitive
diagnosis of pleural TB depends on demonstration of M.
tuberculosis or caseous granulomas in pleural biopsy.
Similarly, the sensitivity of PCR for TB pericarditis was only
15% with pericardial specimens but scored higher with tis-
sue specimens (80%).19 False-negative PCR results for
exudative effusions reflected a low burden of M. tubercu-
losis organisms or hypersensitivity nature.
With an increasing awareness of vaccine strains osteo-
myelitis from neonatal BCG vaccination and modern mo-
lecular diagnostic technique, the diagnosis of BCG vaccine-
induced complication become feasible.20,21 Between 2008
and 2014, we identified three children with osteitis due to
Tokyo-172 BCG strains by specific PCR tests in this case
series.
Limitations
We acknowledge that a few limitations of our study exist.
Firstly, our study focused on patients with high probability
of TB disease in an endemic area with TB together with
universal neonatal BCG program. Secondly, a proportion of
TB cases may be missed by bacteriological culture and that
would bias the estimates of sensitivity and specificity of the
IGRA in this study. Thirdly, the number of patients below 2
years of age and immunodeficiency are low, therefore oury of QuantiFERONeTB Gold In-Tube test in pediatric tuberculosis
d Infection (2015), http://dx.doi.org/10.1016/j.jmii.2015.07.012
Table 3 Sensitivity, specificity, positive predictive values, and negative predictive values for tuberculin skin test and
QuantiFERON-TB Gold in-Tube assay as the reference standard for tuberculous diseases.
Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI) NPV (95% CI)
TST 62.5 (24.5e91.5) 95.2 (76.2e99.9) 83.3 (41.7e99.6) 86.9 (67.0e96.3)
QFG-IT 100 (63.1e100) 97.1 (85.1e99.9) 88.9 (51.7e99.7) 100 (89.7e100)
CIZ confidence interval; NPVZ negative predictive value; PPVZ positive predictive value; QFG-ITZ QuantiFERON-TB Gold in-Tube;
TST Z tuberculin skin test.
6 K.-S. Wong et al.
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young age and those living in areas of TB low-prevalence.
In conclusion, this study demonstrated that QFG-IT had a
higher sensitivity of 100% compared with 62.5% for TST in a
pediatric population of immediate-burden TB population
with national BCG program. With increasing recognition of
BCG osteitis, positive TST but negative QFG-IT is the first
clue of extrapulmonary TB involvement of Tokyo-172 BCG
strains.
Conflicts of interest
The authors declare no conflicts of interest with respect to
the research, authorship, and publication of this article.
Acknowledgments
KS Wong, HC Hu, Yhu-Chering Huang, Lin TY contributed to
conception, design, analysis and interpretation, drafting,
and critical revision of the manuscript. Yen-Chun Huang, CH
Wen contributed to data acquisition, analysis, and inter-
pretation of the data.
References
1. Center for Disease Control. Tuberculosis Annual Report, 2001:
Strategies for Tuberculosis Control. Taipei: Center for Disease
Control, Department of Health, Taiwan.
2. Chan PC, Huang LM, Kuo HS. Is neonatal Bacillus Calmette-
Guerin vaccination protective in Taiwan? J Formos Med Assoc
2008;107:195e7.
3. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B,
Vernon A. Guidelines for using the QuantiFERON-TB Gold test
for detecting Mycobacterium tuberculosis infection, United
States. MMWR Recomm Rep 2005;54:49e55.
4. Starke JR. Diagnosis of tuberculosis in children. Pediatr Infect
Dis J 2000;19:1095e6.
5. Detjen AK, Keil T, Roll S, Hauer B, Mauch H, Wahn U, et al.
Interferon-g release assays improve the diagnosis of tubercu-
losis and nontuberculous mycobacterial disease in children in a
country with a low incidence of tuberculosis. Clin Infect Dis
2007;45:322e8.
6. Connell TG, Ritz N, Paxton GA, Buttery JP, Curtis N,
Ranganathan SC, et al. A three-way comparison of tuberculin
skin testing, QuantiFERON-TB gold and T-SPOT.TB in children.
PLoS One 2008;3:e2624.
7. Chan PC, Chang LY, Wu YC, Lu CY, Kuo HS, Lee CY, et al. Age-
specific cut-offs for the tuberculin skin test to detect latentPlease cite this article in press as: Wong K-S, et al., Diagnostic utilit
disease in Taiwanese children, Journal of Microbiology, Immunology antuberculosis in BCG-vaccinated children. Int J Tuberc Lung Dis
2008;12:1401e6.
8. World Health Organization. Guideline for national tuberculosis
programs on the management of tuberculosis in children.
WHO/HTM/STB/2006.371. Geneva, Switzerland: WHO; 2006.
9. Comstock GW, Edwards LB, Philip RN, Winn WA. A comparison
in the United States of America of two tuberculins, PPD-S and
PPD RT 23. Bull World Health Organ 1964;31:161e70.
10. Belknap R, Daley CL. Interferon-gamma release assays. Clin
Lab Med 2014;34:337e49.
11. Starke JR. Interferon- g release assays for diagnosis of tuber-
culosis infection and disease in children. Pediatrics 2014;134:
e1763e73.
12. American Academy of Pediatrics. Summaries of Infectious
Diseases. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS,
editors. Red Book: 2012 Report of the Committee on Infectious
Diseases. Elk Grove Village IL: American Academy of Pediat-
rics; 2012. p. 736e59.
13. Centers for Disease Control and Prevention. Updated guide-
lines for using interferon gamma release assays to detect
Mycobacterium tuberculosis infection e United States, 2010.
MMWR Morbid Mortal Wkly Report 2010;59:1e13.
14. Palvic I, Topic RZ, Raos M, Aberle N, Nodig S. Interferon-g
release assay for the diagnosis of latent tuberculosis in chil-
dren younger than 5 years of age. Pediatr Infect Dis 2011;30:
866e70.
15. Kampmann B, Whittaker E, Williams A, Walters S, Gordon A,
Martinez-Alier N, et al. Interferon-g release assays do not
identify more children with active tuberculosis than the tu-
berculin skin test. Eur Respir J 2009;33:1374e82.
16. Mandalakas AM, Detjen AK, Hesseling AC, Benedetti A,
Menzies D. Interferon-gamma release assays and childhood
tuberculosis systematic review and meta-analysis. Int J Tuberc
Lung Dis 2011;15:1018e32.
17. Lodha R, Mukherjee A, Saini D, Saini S, Singh V, Singh S, et al.
Role of QuantiFERON-TB In-Tube test in the diagnosis of
intrathoracic childhood tuberculosis. Int J Tuberc Lung Dis
2013;17:1383e8.
18. Trajman A, da Silva Santos Kleiz de Oliveira EF, Bastos ML, Belo
Neto E, Silva EM, da Silva Lourenco MC, et al. Accuracy of
polymerase chain reaction for the diagnosis of pleural tuber-
culosis. Resp Med 2014;108:918e23.
19. Cegielski JP, Devlin BH, Morris AJ, Kitinya JN, Pulipaka UP,
Lema LE, et al. Comparison of PCR, culture, and histopathol-
ogy for diagnosis of tuberculous pericarditis. J Clin Microbiol
1997;35:3254e7.
20. Jou RW, Huang WL, Su WJ. Tokyo-172 BCG vaccination com-
plications, Taiwan. Emerg Infect Dis 2009;15:1525e6.
21. Kwon HJ, Chung BH, Choi BM, Park KU, Kim YK. Severe osteo-
myelitis as a complication of Tokyo-172 BCG vaccination. J
Korean Med Sci 2012;27:221e4.y of QuantiFERONeTB Gold In-Tube test in pediatric tuberculosis
d Infection (2015), http://dx.doi.org/10.1016/j.jmii.2015.07.012
